What is the recommended management for patients with recurrent Urinary Tract Infections (UTIs) and urinary retention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For patients with recurrent urinary tract infections (UTIs) and urinary retention, a CT renal tract is usually not appropriate unless there are underlying risk factors or complications, in which case CTU or MRU may be considered for evaluation. The management of these patients requires a comprehensive approach addressing both conditions simultaneously.

Key Considerations

  • Establishing proper bladder drainage is crucial, typically through clean intermittent catheterization (CIC) performed 4-6 times daily, to reduce infection risk 1.
  • Antibiotic prophylaxis may be necessary, with options including nitrofurantoin, trimethoprim-sulfamethoxazole, or fosfomycin, as guided by urine culture results and clinical guidelines 1.
  • Addressing the underlying cause of retention is vital, which may involve alpha-blockers for prostatic obstruction or surgical intervention for anatomical issues.
  • Patients should increase fluid intake, practice good perineal hygiene, and void immediately after sexual activity to prevent recurrence.
  • Additional prophylaxis with methenamine hippurate or cranberry supplements may be beneficial.

Imaging Recommendations

  • Imaging is usually not appropriate for recurrent uncomplicated lower UTIs in females without known underlying risk factors 1.
  • For patients with recurrent complicated UTIs or those who are nonresponders to conventional therapy, develop frequent reinfections or relapses, or have known underlying risk factors, CTU or MRU are usually appropriate for evaluation 1.
  • The choice between CTU and MRU depends on the clinical context and patient factors, with both considered equivalent alternatives for providing necessary clinical information 1.

From the FDA Drug Label

To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim oral suspension and other antibacterial drugs, sulfamethoxazole and trimethoprim oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis and Proteus vulgaris

The recommended management for patients with recurrent Urinary Tract Infections (UTIs) is to treat with a single effective antibacterial agent, such as sulfamethoxazole and trimethoprim oral suspension. However, there is no direct information in the provided drug labels regarding the use of CT renal tract in patients with recurrent UTIs and urinary retention 2, 2.

  • Key points:
    • Sulfamethoxazole and trimethoprim oral suspension is indicated for the treatment of urinary tract infections due to susceptible strains of certain organisms.
    • The use of CT renal tract is not directly addressed in the provided drug labels.

From the Research

Indications for CT Renal Tract in Recurrent UTI and Retention

  • The use of computed tomography (CT) in the evaluation of recurrent Urinary Tract Infections (UTIs) and urinary retention is supported by several studies 3, 4, 5, 6.
  • CT imaging is highly sensitive and specific in the diagnosis of urolithiasis, which is a common cause of recurrent UTIs and urinary retention 5.
  • The selection of CT or magnetic resonance imaging (MRI) in the evaluation of UTIs depends on several factors, including the presence of contraindications, experience, cost, and availability 3.
  • CT imaging can help in the early detection and management of UTIs, reducing the prevalence and severity of complications 3.
  • In patients with recurrent UTIs and urinary retention, CT imaging can be used to identify underlying structural or functional abnormalities, such as ureteral stones or obstruction, which may be contributing to the development of UTIs 4, 5.

Diagnostic Criteria

  • The diagnosis of recurrent UTIs is typically based on clinical presentation, laboratory results, and imaging findings 7.
  • CT imaging can be used to evaluate the upper and lower urinary tract for signs of infection, obstruction, or other abnormalities 3, 4, 5.
  • The use of CT imaging in the evaluation of recurrent UTIs and urinary retention should be guided by clinical judgment and should take into account the potential risks and benefits of radiation exposure 6.

Management Strategies

  • The management of recurrent UTIs and urinary retention typically involves a combination of antibiotic therapy, drainage of any obstruction, and correction of any underlying anatomical abnormalities 7.
  • CT imaging can be used to guide the management of recurrent UTIs and urinary retention by providing detailed information about the location and extent of any underlying abnormalities 3, 4, 5.
  • The use of CT imaging in the management of recurrent UTIs and urinary retention should be individualized and should take into account the specific needs and circumstances of each patient 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The impacted ureteral stone.

Ultrasound quarterly, 2012

Research

Advances in CT imaging for urolithiasis.

Indian journal of urology : IJU : journal of the Urological Society of India, 2015

Research

Radiological imaging of patients with suspected urinary tract stones: national trends, diagnoses, and predictors.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2011

Research

Managing recurrent urinary tract infections in kidney transplant patients.

Expert review of anti-infective therapy, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.